Capital Investment Management’s Amgen AMGN Stock Holding History

Capital Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-800	Closed	-$281K	–	133
2026 Q1	$281K	Buy	+800	New	+$285K	0.1%	96

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Capital Investment Management's AMGN Position: Q2 2026 in Review

Capital Investment Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 800 shares — an estimated $281K sold.

Capital Investment Management first reported a position in AMGN in Q1 2026 and held it in 1 quarter. The position peaked at $281K in Q1 2026. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Capital Investment Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
Capital Investment Management sold 800 Amgen shares in Q2 2026, an estimated $281K.
Capital Investment Management first reported a position in Amgen in Q1 2026 and held it in 1 quarter.
Capital Investment Management's Amgen position peaked at $281K in Q1 2026.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Capital Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.